The Journal of Cystic Fibrosis is the official journal of the European Cystic Fibrosis Society
Impact Factor 2016
The European Cystic Fibrosis Society is pleased to announce that the official 2016 Impact Factors (IF) were recently released, and the Journal of Cystic Fibrosis (JCF) has increased its IF from the 2015 IF of 3.853 to 4.727. JCF ranks 8th of 59 in the Respiratory System category.
The Journal Impact Factor is published each year by Thomson Reuters. It is a measure of the number of times an average paper in a particular journal is cited during the preceding two years.
JCF has continued to work hard for this achievement, through thoughtful structuring of its editorial pages and continuing growth in our international presence. The ECFS would like to thank the Editor in Chief, Prof. Scott Bell, and the Editorial Board; Their excellent service and work have helped JCF gain its current standings and continue to aid its growth.
Updated 26 June 2017
The journal is devoted to promoting the research and treatment of cystic fibrosis. To this end the journal publishes original scientific articles, editorials, case reports, short communications and other information relevant to cystic fibrosis. There are currently 6 issues a year with supplements. The Journal of Cystic Fibrosis is published by Elsevier and the Editor in Chief is Dr. Scott Bell, Brisbane, Australia.
ECFS Members have a direct link to the online version of the Journal by logging in to their "MY ECFS" account (please see banner above) and clicking on the Journal of CF Tab.
If preferred, ECFS members may create a separate profile on the Elsevier website which will also provide online access. For the instructions to do this, please click here (pdf). For ECFS Members who have created a profile on the Elsevier website, articles can be accessed here (your unique Elsevier login is required)
Articles published in the JCF after two years are freely available. Visit Science Direct, and navigate to prior years.
The European Cystic Fibrosis Society is proud to announce that the the Journal of Cystic Fibrosis has been accepted by Thomson Scientific for inclusion in their “Current Contents” and “Science Citation Index Expanded”.
The journal Impact Factor, published by Thomson Reuters, is a measure of the frequency with which the average article in a journal has been cited in a particular year.
For the Journal of Cystic Fibrosis - the 2014 Impact Factor is in the Respiratory category: 3.475
Call for Papers
The Journal of Cystic Fibrosis welcomes manuscripts on basic and clinical research and epidemiology of CF. Papers may include original articles, short reports, reviews and editorials.
Authors instructions for submission of an article to the Journal of CF can be found here (Elsevier website)
Submitted manuscripts are subject to peer review by members from an international panel of reviewers.